Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Bieck

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Psychopharmacology|August 1, 1988
Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjectsP R Bieck, K H Antonin
Psychopharmacology|January 1, 1986
Metabolic fate of CGS 8216, a benzodiazepine receptor antagonist, in rat and in manM Jedrychowski, E Nilsson, P R Bieck
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
A rapid and sensitive method for the quantitation of levoprotiline in human blood and plasmaM Jedrychowski, E Hoffmann, P R Bieck
Clinical Neuropharmacology|January 1, 1992
Clinical pharmacology of reversible MAO-A inhibitorsP R Bieck, K H Antonin, E Schmidt
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1976
Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and ratU Klotz, K H Antonin, P R Bieck
European Journal of Clinical Pharmacology|June 15, 1976
Comparison of the pharmacokinetics of diazepam after single and subchronic dosesU Klotz, K H Antonin, P R Bieck
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1987
Intra-subject variability of platelet alpha 2-adrenoceptor binding sites in healthy volunteersI W Reimann, C Britzelmeier, P R Bieck
Journal of Neural Transmission. Supplementum|January 1, 1990
Effect of the new selective COMT inhibitor CGP 28014 A on the formation of 3-O-methyldopa (3OMD) in plasma of healthy subjectsP R Bieck, E Nilsson, K H Antonin
Arzneimittel-Forschung|January 1, 1976
Proceedings: Induction of drug metabolizing enzymes in manP R Bieck, K H Antonin, U Klotz
Clinical Neuropharmacology|January 1, 1993
Clinical pharmacology of reversible monoamine oxidase-A inhibitorsP R Bieck, K H Antonin, E Schmidt
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Psychopharmacology|August 1, 1988
Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjectsP R Bieck, K H Antonin
Psychopharmacology|January 1, 1986
Metabolic fate of CGS 8216, a benzodiazepine receptor antagonist, in rat and in manM Jedrychowski, E Nilsson, P R Bieck
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
A rapid and sensitive method for the quantitation of levoprotiline in human blood and plasmaM Jedrychowski, E Hoffmann, P R Bieck
Clinical Neuropharmacology|January 1, 1992
Clinical pharmacology of reversible MAO-A inhibitorsP R Bieck, K H Antonin, E Schmidt
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1976
Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and ratU Klotz, K H Antonin, P R Bieck
European Journal of Clinical Pharmacology|June 15, 1976
Comparison of the pharmacokinetics of diazepam after single and subchronic dosesU Klotz, K H Antonin, P R Bieck
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1987
Intra-subject variability of platelet alpha 2-adrenoceptor binding sites in healthy volunteersI W Reimann, C Britzelmeier, P R Bieck
Journal of Neural Transmission. Supplementum|January 1, 1990
Effect of the new selective COMT inhibitor CGP 28014 A on the formation of 3-O-methyldopa (3OMD) in plasma of healthy subjectsP R Bieck, E Nilsson, K H Antonin
Arzneimittel-Forschung|January 1, 1976
Proceedings: Induction of drug metabolizing enzymes in manP R Bieck, K H Antonin, U Klotz
Clinical Neuropharmacology|January 1, 1993
Clinical pharmacology of reversible monoamine oxidase-A inhibitorsP R Bieck, K H Antonin, E Schmidt
Pageof 5